TITLE

Overview of Warfarin Treatment and Answers to Questions

AUTHOR(S)
Altunbaş, Gökhan; Ercan, Süleyman; Davutoğlu, Vedat; Al, Behçet
PUB. DATE
March 2013
SOURCE
Journal of Academic Emergency Medicine / Akademik Acil Tip Olgu ;2013, Vol. 12 Issue 1, p38
SOURCE TYPE
Academic Journal
DOC. TYPE
Article
ABSTRACT
The increased frequency of referral of patients with warfarin related complications to the emergency unit is worthy of our attention nowadays. The most common reason for this is its role in the prevention of stroke in atrial fibrillation and increased usage of this drug for the high rate of valve surgery. Bleeding in case of a supratherapeutic effect, its relation with thrombotic complications at subtherapeutic levels and additionally the presence of high risk of drug-drug interaction are important aspects of this drug in routine practice of the cardiologist and emergency physician. Our aim is to review knowledge concerning warfarin in routine practice.
ACCESSION #
88088627

 

Related Articles

  • Warfarin and atrial fibrillation: from ideal to real the warfarin affaire. Molteni, Mauro; Cimminiello, Claudio // Thrombosis Journal;2014, Vol. 12 Issue 1, p5 

    Vitamin K Antagonists (VKAs) are widely used in clinical practice and nearly 1% of the entire population receives oral anticoagulation at least once in life. However, the rate of prescription of anticoagulation is low, compared to what it should be. No more than 50-60% of patients affected by...

  • Warfarin for stroke prevention in hemodialysis patients with non-valvular atrial fibrillation. Badr, Souzi; Cameron, Karen; Battistella, Marisa // CANNT Journal;Jul-Sep2015, Vol. 25 Issue 3, p22 

    The article discusses how the anticoagulant warfarin can be used to prevent strokes in hemodialysis patients with non-valvular atrial fibrillation (AF). It covers the pathophysiology of atrial fibrillation and concludes that warfarin's ability to reduce stroke rate is conflicting based on...

  • The Unmet Needs in the Management of Stroke Prevention in Atrial Fibrillation. Miller, Michael // Journal of Managed Care Medicine;2013, Vol. 16 Issue 3, p58 

    No abstract available.

  • Anticoagulants better in AF patients. Tyndall, Keith // British Journal of Cardiac Nursing;Nov2013, Vol. 8 Issue 11, p524 

    A letter to the editor in response to the article "The Role of Anticoagulants in AF and Stroke Risk" published in the October 2013 issue of the "British Journal of Cardiac Nursing" is presented.

  • The epidemic of pre-injury oral antiplatelet and anticoagulant use. Berndtson, A.; Coimbra, R. // European Journal of Trauma & Emergency Surgery;Dec2014, Vol. 40 Issue 6, p657 

    Background: As the population ages, an increasing number of trauma patients are taking antiplatelet and anticoagulant medications (ACAP) prior to their injuries. These medications increase their risk of hemorrhagic complications, particularly intracerebral hemorrhage. Clopidogrel and warfarin...

  • Warfarin for Prevention of Thrombosis Among Long-Term Care Residents with Atrial Fibrillation: Evidence of Continuing Low Use Despite Consideration of Stroke and Bleeding Risk. Reardon, Gregory; Nelson, Winnie; Patel, Aarti; Philpot, Tommy; Neidecker, Marjorie // Drugs & Aging;2013, Vol. 30 Issue 6, p417 

    Objectives: The aims of the study were to evaluate usage rates of warfarin in stroke prophylaxis and the association with assessed stages of stroke and bleeding risk in long-term care (LTC) residents with atrial fibrillation (AFib). Methods: A cross-sectional analysis of two LTC databases (the...

  • Apixaban vs Warfarin for Atrial Fibrillation. Crawford, Michael H. // Clinical Cardiology Alert;Feb2013, Vol. 32 Issue 2, p11 

    An abstract of the article "Efficacy of apixaban when compared with warfarin in relation to renal function in patients with atrial fibrillation: Insights from the ARISTOTLE trial," by S. Hohnloser and colleagues is presented.

  • Use of dabigatran to prevent stroke in patients with atrial fibrillation. Mooney, Tracy // Nursing Standard;3/6/2013, Vol. 27 Issue 27, p35 

    Atrial fibrillation (AF) is a major risk factor for ischaemic stroke. Anticoagulant therapy, such as warfarin, is prescribed to prevent stroke in patients with AF. Careful monitoring is required to achieve safe and effective levels of warfarin in the blood. In March 2012, the National Institute...

  • Risk of Bleeding with Warfarin Therapy for Atrial Fibrillation. Dimarco, John P. // Clinical Cardiology Alert;Jan2013, Vol. 32 Issue 1, p5 

    The author comments on a study by T. Gomes and colleagues on rates of hemorrhage during warfarin therapy for atrial fibrillation (AF), which revealed that the risk of hemorrhage is high in patients with AF on warfarin therapy. He opines that the rate of bleeding is very high during the first...

Share

Read the Article

Courtesy of VIRGINIA BEACH PUBLIC LIBRARY AND SYSTEM

Sorry, but this item is not currently available from your library.

Try another library?
Sign out of this library

Other Topics